Skip to Main Content

Paper Details

Risk of late toxicity in men receiving dose-escalated hypofractionated intensity modulated prostate radiation therapy: results from a randomized trial.
Int J Radiat Oncol Biol Phys
112
2014
Author NameAffiliation
Andrew K LeeThe University of Texas, MD Anderson Cancer Center
  • 1 - 1

Datasets

Release 1.2